Difference between revisions of "Main Page"

Revision as of 18:58, 16 November 2018

The biomarker for SensUs 2019 is adalimumab.

Revision as of 19:51, 15 November 2018 (view source) Techsensus (talk \| contribs) ← Older edit		Revision as of 18:58, 16 November 2018 (view source) Techsensus (talk \| contribs) Newer edit →
Line 1:		Line 1:
	=== SensUs 2019 ===		=== SensUs 2019 ===
−	The biomarker for SensUs 2019 is [[~~Adalimumab~~]].	+	The biomarker for SensUs 2019 is [[adalimumab]].